ARTICLE | Company News
Nabriva's lefamulin gets QIDP and Fast Track
October 9, 2014 2:20 AM UTC
Nabriva Therapeutics AG (Vienna, Austria) said FDA granted its lefamulin ( BC-3781) Qualified Infectious Disease Product (QIDP) and Fast Track designations to treat community-acquired bacterial pneumo...